Effect of central precocious puberty and gonadotropin-releasing hormone analogue treatment on peak bone mass and final height in females

European Journal of Pediatrics

Volumn 157, Issue 5, 1998, Pages 363-367

  Bertelloni, S ^a,b   Baroncelli, G I ^a   Sorrentino, M C ^a   Perri, G ^a   Saggese, G ^a  

^a UNIVERSITY OF PISA   (Italy)

^b Dept of Pediatrics ^*  (Italy)

Author keywords

Bone mineral density; Central precocious puberty; Final height Gn RH analogue treatment; Peak bone mass

Indexed keywords

BUSERELIN; GONADORELIN DERIVATIVE; TRIPTORELIN;

BODY HEIGHT; BONE AGE; BONE MASS; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; DUAL ENERGY X RAY ABSORPTIOMETRY; FEMALE; HORMONAL THERAPY; HUMAN; INTRAMUSCULAR DRUG ADMINISTRATION; INTRANASAL DRUG ADMINISTRATION; LUMBAR VERTEBRA; PRECOCIOUS PUBERTY; PRESCHOOL CHILD; PRIORITY JOURNAL; REVIEW; SCHOOL CHILD;

ADOLESCENT; BODY HEIGHT; BONE DENSITY; BUSERELIN; CHILD; CHILD, PRESCHOOL; FEMALE; GONADOTROPIN-RELEASING HORMONE; HUMANS; PUBERTY, PRECOCIOUS; REGRESSION ANALYSIS; TRIPTORELIN;

EID: 0031978821     PISSN: 03406199     EISSN: None     Source Type: Journal    
DOI: 10.1007/s004310050831     Document Type: Review

References (30)

1. Antoniazzi F, Bertoldo F, Zamboni G, Valentini R, Sipresi S, Cavallo L, Adami S, Tatò L (1995) Bone mineral metabolism in girls with central precocious puberty during gonadotropin-releasing hormone agonist treatment. Eur J Endocrinol 133:412-417
2. Armamento-Villareal R, Villareal DT, Avioli LV, Civitelli R (1992) Estrogen status and heredity are major determinants of premenopausal bone mass. J Clin Invest 90:2464-2471
3. Bayley N, Pinneau SR (1952) Tables for predicting adult height from skeletal age: revised for use with the Greulich and Pyle standards. J Pediatr 40:432-441
4. Bertelloni S, Baroncelli GI, Battini R, Perri G, Saggese G (1995) Short-term effect of testosterone treatment on reduced bone density in boys with constitutional delay of puberty. J Bone Miner Res 10:1488-1495
5. Brauner R, Adan L, Malandry F, Zantleifer D (1994) Adult height in girls with idiopathic true precocious puberty. J Clin Endocrinol Metab 79:415-420
6. Dawood MY (1994) Hormonal therapies for endometriosis: implications for bone metabolism. Acta Obstet Gynecol [Suppl] 159:22-34
7. Dodin S, Lemay A, Maheux R, Dumont M, Turcot-Lemay (1991) Bone mass in endometriosis patients treated with GnRH agonist implant or danazol. Obstet Gynecol 77:410-415
8. Finkelstein JS, Klibanski A, Neer RM, Doppelt SH, Rosenthal DI, Segre GV, Crowley WFJr (1989) Increases in bone density during treatment of men with idiopathic hypogonadotropic hypogonadism. J Clin Endocrinol Metab 69:776-783
9. Finkelstein JS, Neer RM, Biller BMK, Crawford JD, Klibanski A (1992) Osteopenia in men with history of delayed puberty. N Engl J Med 326:600-604
10. Greulich WW, Pyle SI (1959) Radiographic atlas of skeletal development of the hand and wrist. 2nd end. Stanford University Press, Stanford
11. Kletter GB, Kelch RP (1994) Effects of gonadotropin-releasing hormone analog therapy on adult stature in precocious puberty. J Clin Endocrinol Metab 79:331-334
12. Krall EA, Dawson-Hughes B (1993) Heritable and life-style determinants of bone mineral density. J Bone Miner Res 8:1-9
13. Lee PA (1994) Laboratory monitoring of children with precocious puberty. Arch Pediatr Adolesc Med 148:369-376
14. Lonzer MD, Imrie R, Rogers D, Worley D, Licata A, Secic M (1996) Effects of heredity, age, weight, puberty, activity, and calcium intake on bone mineral density in children. Clin Pediatr 35:185-189
15. Matkovic V, Fontana D, Tominac C, Goel P, Chesnut CH III (1990) Factors that influence peak bone mass formation: a study of calcium balance and the inheritance of bone mass in adolescent females. Am J Clin Nutr 52:878-888
16. Matkovic V, Jelic T, Wardlaw GM, Ilich JZ, Goel PK, Wright JK, Andon MB, Smith KT, Heaney RP (1994) Timing of peak bone mass in Caucasian females and implication for the prevention of osteoporosis. Inference from a cross-sectional model. J Clin Invest 93:799-808
17. Matta WH, Shaw RW, Hesp R, Evans R (1988) Reversible trabecular bone density loss following induced hypooestrogenism with the GnRH analogue buserelin in premenopausal women. Clin Endocrinol (Oxf) 29:45-51
18. Mora S, Weber G, Guarneri MP, Nizzoli G, Pasolini D, Chiumello G (1992) Effect of estrogen replacement therapy of bone mineral content in girls with Turner syndrome. Obstet Gynecol 79:747-751
19. Neely EK, Bachrach LK, Hintz RL, Slemenda CW, Feezle L, Pescovitz OH (1995) Bone mineral density during treatment of central precocious puberty. J Pediatr 127:819-822
20. Oerter KE, Manasco PK, Barnes KM, Jones J, Hill S, Cutler GB Jr (1993) Effects of luteinizing hormone-releasing hormone agonists on final height in luteinizing hormone-releasing hormone-dependent precocious puberty. Acta Paediatr [Suppl] 388:62-68
21. Oostdijk W, Rikken B, Schreuder S, Otten B, Odink R, Rouwé C, Jansen M, Gerver WJ, Waelkens J, Drop S (1996) Final height in central precocious puberty after long term treatment with a slow release GnRH agonist. Arch Dis Child 75:292-297
22. Ott SM (1990) Attainment of peak bone mass. J Clin Endocrinol Metab 71:1082A-1082C
23. Saggese G, Bertelloni S, Baroncelli GI, Battini R, Franchi G (1993) Reduction of bone density: an affect of gonadotropin-releasing hormone analogue treatment in central precocious puberty. Eur J Pediatr 152:717-720
24. 3. J Clin Endocrinol Metab 70:1055 1061
25. Shankar R, Pescovitz OH (1995) Precocious puberty. Adv Endocrinol Metab 6:55-89
26. Takahashi Y, Minamitani K, Kobayashi Y, Minagawa M, Yasuda T, Niimi H (1996) Spinal and femoral bone mass accumulation during normal adolescence: comparison with female patients with sexual precocity and with hypogonadism. J Clin Endocrinol Metab 81:1248-1253
27. Tanner JM, Whitehouse RH, Takaishi M (1966) Standards from birth to maturity for height, weight, height velocity: British children. Arch Dis Child 41:613-635
28. Theintz G, Buchs B, Rizzoli R, Sloman D, Clavien H, Sizonenko PC, Bonjour J-PH (1992) Longitudinal monitoring of bone mass accumulation in healthy adolescents: Evidence for a marked reduction after 16 years of age at the levels of lumbar spine and femoral neck in female subjects. J Clin Endocrinol Metab 75:1060-1065
29. Waibel-Treber S, Minne HW, Scharla SH, Bremen T, Ziegler R, Leyendecker G (1989) Reversible bone loss in women treated with GnRH-agonists for endometriosis and uterine leiomyoma. Hum Reprod 4:384-388
30. Zachmann M (1992) Assessment of skeletal and sexual maturity: theoretical and practical aspects. Clin Pediatr Endocrinol [Suppl] 3:15-33